Emerging biopharmaceuticals from bioactive peptides derived from marine organisms.

Biologically active natural products are spontaneous medicinal entrant, which encourage synthetic access for enhancing and supporting drug discovery and development. Marine bioactive peptides are considered as a rich source of natural products that may provide long term health, in addition to many prophylactic and curative medicinal drug treatments. In spite of the large literature concerning marine peptides have been collected, which shows high potential of nutraceutical and therapeutic efficacy encompassing wide spectra of bioactivities against a number of infection causing agents. Their antimicrobial, antimalarial, antitumor, antiviral and cardio protective actions have achieved the attention of the pharmaceutical industry towards new design of drug formulations, for treatment and prevention of several infections. However, the mechanism of action of many peptide molecules have been still untapped. So in this regard, this paper reviews several peptide compounds by which they interfere with human pathogenesis. This knowledge is one of the key tool to be understood especially for the biotransformation of biomolecules into targeted medicines. The fact that different diseases have the capability to fight at different sites inside the body can lead to a new wave of increasing the chances to produce targeted medicines. This article is protected by copyright. All rights reserved.